Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Trial of Hippocampal-sparing Prophylactic Cranial Irradiation (HS-PCI) in Locally Advanced (Stage IIIA/IIIB) Adenocarcinoma of the Lung

NCT02341170 is registered in ClinicalTrials.gov with Universitätsmedizin Mannheim as lead sponsor.

NCT NCT02341170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02341170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Trial of Hippocampal-sparing Prophylactic Cranial Irradiation (HS-PCI) in Locally Advanced (Stage IIIA/IIIB) Adenocarcinoma of the Lung
Lead sponsor
Universitätsmedizin Mannheim
Phase
Not applicable
Overall status
Withdrawn
Start date
January 31, 2016
Completion date
March 31, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, lung cancer, lymphatic metastasis